Showing results (41-50 of 109) with videos related to

Sort By:
Pageof 11
Molecular Oncology|August 17, 2018
From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world settingSteven P Rowe, Brandon Luber, Monique Makell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2012
Durable cancer regression off-treatment and effective reinduction therapy with an anti-PD-1 antibodyEvan J Lipson, William H Sharfman, Charles G Drake, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody ComparisonJoel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
Cancer Immunology Research|January 14, 2014
PD-L1 expression in the Merkel cell carcinoma microenvironment: association with inflammation, Merkel cell polyomavirus and overall survivalEvan J Lipson, Jeremy G Vincent, Myriam Loyo, et al.
Annals of the Rheumatic Diseases|June 17, 2016
Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumabLaura C Cappelli, Anna Kristina Gutierrez, Alan N Baer, et al.
The British Journal of Dermatology|July 27, 2025
Merkel Cell Carcinoma in Solid Organ Transplant Recipients: Prognosis and Response to ImmunotherapyTomoko Akaike, Peter Y Ch'en, Daniel S Hippe, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Health-related quality of life with nivolumab plus relatlimab versus nivolumab monotherapy in patients with previously untreated unresectable or metastatic melanoma: RELATIVITY-047 trialDirk Schadendorf, Hussein Tawbi, Evan J Lipson, et al.
Cell Reports. Medicine|February 22, 2023
Combinatorial biomarker for predicting outcomes to anti-PD-1 therapy in patients with metastatic clear cell renal cell carcinomaJulie Stein Deutsch, Evan J Lipson, Ludmila Danilova, et al.
JAMA Oncology|March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for ImmunotherapyElizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2021
A Uniform Computational Approach Improved on Existing Pipelines to Reveal Microbiome Biomarkers of Nonresponse to Immune Checkpoint InhibitorsFyza Y Shaikh, James R White, Joell J Gills, et al.
Pageof 11